Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 11 Sept 2026 for Edwards Lifesciences Corp, €30k. Read the official filing
Filing timeline
BuySaleDaveen Chopra
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Daveen Chopra: trading record in brief
This profile gathers the share dealings of Daveen Chopra in Edwards Lifesciences Corp, where the filings describe the role as senior executive. The record holds 41 filings, for trades running from 4 May 2021 to 11 September 2026.
No open-market purchase appears, only 11 sales worth €3.5M. Other entries cover 16 share grants and 14 option exercises. Since January 2026: no purchases and 3 sales on the market.
On 11 September 2026 came the latest disclosure, a share grant for €30k in Edwards Lifesciences Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daveen Chopra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
398 shares@ US$86.77Common StockSEC:0001225208-26-007775:0
31,800 shares@ US$72.680.0044% mcap20.1% of flowCommon StockSEC:0001225208-26-007335:0
1,154 shares@ US$91.76140.0002% mcap0.9% of flowCommon StockSEC:0001225208-26-007335:1
30,646 shares@ US$90.99220.0053% mcap24.3% of flowCommon StockSEC:0001225208-26-007335:2
1,500 shares@ US$84.60350.0002% mcap1.8% of flowCommon StockSEC:0001225208-26-005576:0
2,000 shares@ US$84.37512.7% of flowCommon StockSEC:0001225208-25-009873:0
3,205 shares0Common StockSEC:0001225208-25-007991:0
2,500 shares@ US$81.9463.4% of flowCommon StockSEC:0001225208-25-007460:0
1,500 shares@ US$75.0751.6% of flowCommon StockSEC:0001225208-25-005388:0
580 shares@ US$73.680.6% of flowCommon StockSEC:0001225208-25-004998:0
627 shares@ US$74.920.7% of flowCommon StockSEC:0001225208-25-004944:0
291 shares@ US$75.650.3% of flowCommon StockSEC:0001225208-25-004767:0
1,750 shares@ US$73.27012.0% of flowCommon StockSEC:0001225208-24-010631:0
1,250 shares@ US$69.95011.3% of flowCommon StockSEC:0001225208-24-008118:0
821 shares@ US$86.721.1% of flowCommon StockSEC:0001225208-24-005981:0
7,000 shares0Common StockSEC:0001225208-24-005889:0
291 shares@ US$85.060.4% of flowCommon StockSEC:0001225208-24-005701:0
7,000 shares@ US$59.25676.3% of flowCommon StockSEC:0001225208-24-002654:0
7,000 shares@ US$59.25676.2% of flowCommon StockSEC:0001225208-23-011152:0
3,500 shares@ US$59.25673.2% of flowCommon StockSEC:0001225208-23-010794:0
8,500 shares@ US$59.25677.9% of flowCommon StockSEC:0001225208-23-009259:0
8,500 shares@ US$59.25677.7% of flowCommon StockSEC:0001225208-23-008737:0
1,500 shares@ US$76.69361.7% of flowCommon StockSEC:0001225208-23-008545:0
6,475 shares0Common StockSEC:0001225208-23-005914:0
3,413 shares0Common StockSEC:0001225208-23-005619:0
25 of 41 declarations
